https://www.openbell.ai/ 2026-10-01T16:08:08.803Z hourly 1.0 https://www.openbell.ai/support 2026-10-01T16:08:08.803Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-01T16:08:08.803Z monthly 0.5 https://www.openbell.ai/terms 2026-10-01T16:08:08.803Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-01T16:08:08.803Z hourly 0.8 https://www.openbell.ai/news/TOL:1790870609959 2026-10-01T16:03:29.959Z daily 0.9 https://cdn.brandfetch.io/TOL/w/400/h/400?c=1idopYfmtR7ZKg8QMud This Toll Brothers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday Morgan Stanley analyst Adam Kramer has initiated coverage on Toll Brothers, Inc. (NYSE: TOL) with an Overweight rating and set a price target of $159, while the stock closed at $134.75 on Wednesday. This marks a positive outlook for the company as analysts begin to reassess its market position. https://www.openbell.ai/news/LQDA:1790870600770 2026-10-01T16:03:20.770Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Stock-Market-Chart-Showing-Falling-Equit.jpg?width=250&height=187 Liquidia Stock Extends Slide Following US Court Ruling in Patent Dispute Liquidia Corp (NASDAQ: LQDA) shares fell 14.64% to $25.83 following a U.S. District Court ruling that upheld two claims of a patent held by United Therapeutics, which Liquidia is accused of infringing. The court's decision may lead to the FDA withdrawing approval for Liquidia's Yutrepia for treating pulmonary hypertension associated with interstitial lung disease, potentially restricting its market availability. Liquidia's CEO stated the company plans to pursue all available appellate options and intends to submit a supplement to the FDA to remove the disputed indication from Yutrepia's label. https://www.openbell.ai/news/CVS:1790870387795 2026-10-01T15:59:47.795Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Chandler--Arizona---April-08-2023cvs-Hea.jpg?width=250&height=187 Cardinal Health, McKesson Double Down on CVS Deals Through 2032 Cardinal Health Inc. has entered into a binding Letter of Intent to extend its distribution agreement with CVS Health Inc. through June 30, 2032, reaffirming its fiscal year 2027 adjusted earnings growth guidance of 13% to 15%, equating to $12.40-$12.60 per share. Similarly, McKesson Corporation has signed an agreement to extend its partnership with CVS Health for pharmaceutical distribution until June 2032, maintaining its fiscal 2027 adjusted earnings outlook of $44.20 to $45 per share. Following these announcements, McKesson shares rose by 4.28% to $890.35, while Cardinal Health shares increased by 2.94% to $229.05. https://www.openbell.ai/news/RDW:1790870369660 2026-10-01T15:59:29.660Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/RedwireStuttgart--Germany---09-04-2022-S.jpg?width=250&height=187 Honda Wants Robots to Handle Routine Lab Work Astronauts Do in Space Honda Motor Co. Ltd. is collaborating with Redwire Corporation to develop a robotics system aimed at automating routine laboratory work for future commercial space stations. The system will integrate Honda's multi-fingered robotic hand with Redwire's STAARK robotic arm to enhance in-orbit research workflows. At the time of publication, Redwire shares increased by 1.48% to $10.59, while Honda shares decreased by 0.08% to $31.57. https://www.openbell.ai/news/HPE:1790870355495 2026-10-01T15:59:15.495Z daily 0.9 https://cdn.brandfetch.io/HPE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Hewlett Packard, Raises Price Target to $72 Morgan Stanley analyst Meta Marshall has maintained an Overweight rating on Hewlett Packard (NYSE: HPE) and increased the price target from $67 to $72. This adjustment reflects positive sentiment towards the company's performance and potential growth. https://www.openbell.ai/news/RDDT:1790870300470 2026-10-01T15:58:20.470Z daily 0.9 https://cdn.brandfetch.io/RDDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Reddit; Shares Move Higher; Traders Circulate Report Saying Co. Revenue Is Way Above The Street Numbers As Of September 30th openbell Financial News https://www.openbell.ai/news/XOM:1790870184141 2026-10-01T15:56:24.141Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Exxon-Mobil.jpg?width=250&height=187 This ExxonMobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday Wells Fargo analyst Sam Margolin downgraded ExxonMobil Holdings Corporation (NYSE: XOM) from Overweight to Equal-Weight with a price target of $182, while the stock closed at $162.75 on Wednesday. Other notable downgrades include Liquidia Corporation from Buy to Neutral and Sigma Lithium Corporation from Outperform to Market Perform, with respective price targets of $30 and $10. Analysts are adjusting their ratings across multiple companies, reflecting shifts in market sentiment. https://www.openbell.ai/news/MU:1790870120617 2026-10-01T15:55:20.617Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Reiterates Overweight on Micron Technology, Maintains $1200 Price Target Morgan Stanley analyst Joseph Moore has reiterated an Overweight rating on Micron Technology (NASDAQ: MU) and has maintained a price target of $1200 for the stock. This endorsement suggests confidence in Micron's performance and potential growth. https://www.openbell.ai/news/IBM:1790870013981 2026-10-01T15:53:33.981Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Ibm-Logo-On-Smartphone-Screen-With-Stock.jpg?width=250&height=187 IBM Is Betting AI’s Next Big Market Won’t Live in the Cloud IBM has announced that its AI software-development platform, IBM Bob, will now be available for on-premises and private-cloud environments, allowing sensitive data to remain within customer-controlled infrastructure. This move addresses challenges related to data residency and sovereignty, particularly for industries like finance and healthcare. In its second-quarter results, IBM reported $17.2 billion in revenue, with its software business growing 5% year-over-year to $7.8 billion, and it anticipates a constant-currency revenue growth of 4% to 5% by 2026. https://www.openbell.ai/news/PFE:1790869879951 2026-10-01T15:51:19.951Z daily 0.9 https://cdn.brandfetch.io/PFE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Florida Attorney General Uthmeier Sues Pfizer Over Alleged Misleading Advertising Of Its COVID Vaccine Florida Attorney General James Uthmeier has filed a lawsuit against Pfizer and its CEO Dr. Albert Bourla, alleging misleading advertising related to its COVID-19 vaccine. The lawsuit claims that the company made false statements about the vaccine's efficacy and safety, which may have influenced public perception and vaccination rates. This legal action could have implications for Pfizer's reputation and operations in the pharmaceutical market. https://www.openbell.ai/news/UTHR:1790869791969 2026-10-01T15:49:51.969Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/United-Therapeutics.jpg?width=250&height=187 This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday BTIG analyst Julian Harrison upgraded United Therapeutics Corporation (NASDAQ: UTHR) from Neutral to Buy, setting a price target of $728. The stock closed at $541.89 on Wednesday. This upgrade is part of a broader trend, as several companies received analyst upgrades, reflecting positive sentiment in the market. https://www.openbell.ai/news/ZION:1790869760927 2026-10-01T15:49:20.927Z daily 0.9 https://cdn.brandfetch.io/ZION/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Underweight on Zions Bancorp, Lowers Price Target to $65 JP Morgan analyst Anthony Elian has maintained an Underweight rating on Zions Bancorp (NASDAQ: ZION) and has lowered the price target from $75 to $65. This adjustment reflects a more cautious outlook on the company's performance. https://www.openbell.ai/news/ACN:1790869640461 2026-10-01T15:47:20.461Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Warsaw--Poland---May-2020-Accenture-Comp.jpg?width=250&height=187 Accenture Earnings Lift Software and IT Services Stocks: Cognizant, IBM, Wipro Rise on Thursday Accenture (NYSE: ACN) reported fourth-quarter fiscal 2026 earnings of $3.29 per share, surpassing the analyst estimate of $3.18, with revenue rising 6% year-over-year to $18.70 billion, also above expectations. The company provided a positive fiscal 2027 outlook, projecting revenue between $76.43 billion and $78.65 billion, exceeding the $76.41 billion estimate. Following Accenture's results, software and IT services stocks saw gains, with Cognizant rising 11.70% and IBM increasing by 5.32%. https://www.openbell.ai/news/AAON:1790869448756 2026-10-01T15:44:08.756Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/ChatGPT-Image-Oct-1--2026--10-43-25-AM.png?width=250&height=187 Alpha Buying: Insiders Are Buying the Data Center Cooling Boom Madison Air Solutions (MAIR) is acquiring ebm-papst for $5.4 billion to enhance its air technology offerings, with expectations of $160 million in annual cost savings by year three. AAON reported a 100% increase in second-quarter sales to $627 million, driven by a 216.2% rise in BASX-branded sales, and raised its full-year sales growth outlook to 55-60%. Both companies are experiencing significant insider buying, indicating confidence in their growth prospects amid a recovering HVAC market. https://www.openbell.ai/news/ZION:1790869412326 2026-10-01T15:43:32.326Z daily 0.9 https://cdn.brandfetch.io/ZION/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evercore ISI Group Maintains Underperform on Zions Bancorp, Lowers Price Target to $64 Evercore ISI Group analyst John Pancari has maintained an 'Underperform' rating on Zions Bancorp (NASDAQ: ZION) and has lowered the price target from $68 to $64. https://www.openbell.ai/news/AMOD:1790869219429 2026-10-01T15:40:19.429Z daily 0.9 https://cdn.brandfetch.io/AMOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Alpha Modus Closes PIPE Deal, Receives 3,170 Bitcoin On Sept. 30; Subsidiary Owns 3,170 Bitcoin Valued At Over $250M As Of Sept. 30 Alpha Modus has successfully closed a PIPE (Private Investment in Public Equity) deal, resulting in the receipt of 3,170 Bitcoin on September 30. The subsidiary now owns these Bitcoin, which are valued at over $250 million as of the same date. This strategic move may impact the company's financial standing and market perception. https://www.openbell.ai/news/AMOD:1790869190283 2026-10-01T15:39:50.283Z daily 0.9 https://cdn.brandfetch.io/AMOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Alpha Modus Closes PIPE Deal, Receives 3,170 Bitcoin On Sept. 30; Subsidiary Owns 3,170 Bitcoin Valued At Over $250M As Of Sept. 30 Alpha Modus has successfully closed a PIPE deal, receiving 3,170 Bitcoin on September 30, which is valued at over $250 million as of that date. The subsidiary of Alpha Modus now owns this Bitcoin, significantly impacting its asset portfolio. The stock ticker for Alpha Modus is AMOD. https://www.openbell.ai/news/REGN:1790869035426 2026-10-01T15:37:15.426Z daily 0.9 https://cdn.brandfetch.io/REGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Regeneron Pharmaceuticals Announces Its Results From Phase 2 COURAGE Study Of Trevogrumab Shows 70% Prevention Of Muscle Loss Associated With Semaglutide Treatment; Lower Dose Of Trevogrumab Did Not Enhance Weight Loss Achieved With Semaglutide Alone Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced results from its Phase 2 COURAGE trial, which demonstrated that trevogrumab can prevent 70% of muscle loss associated with semaglutide treatment in individuals with obesity. The trial results were shared at the EASD Annual Meeting and are set to be published in The Lancet. Following these findings, Regeneron plans to initiate another Phase 2 trial to evaluate trevogrumab in combination with GLP-1 receptor agonists for older adults experiencing obesity-related muscle loss. https://www.openbell.ai/news/CALM:1790869028197 2026-10-01T15:37:08.197Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Milan--Italy---August-10--2017-Cal-Maine.jpg?width=250&height=187 Cal-Maine Shares Crack After Wider-Than-Expected Loss, Muted Egg Prices Cal-Maine Foods Inc (NASDAQ: CALM) reported a wider-than-expected adjusted loss of $1.23 per share for the first quarter of fiscal 2027, compared to consensus estimates of a loss of 77 cents per share. Net sales fell by 41.5% to $539.6 million, with a 40.4% decline in average selling price to $1.48 per dozen. The company's shares dropped by 3.28% to $65.83 following the announcement, and the price target was cut from $80 to $70 by analyst Pooran Sharma, who maintained an Equal-Weight rating amid concerns over muted egg prices and industry supply imbalances. https://www.openbell.ai/news/TCBI:1790868906408 2026-10-01T15:35:06.408Z daily 0.9 https://cdn.brandfetch.io/TCBI/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Underweight on Texas Capital Bancshares, Lowers Price Target to $100 JP Morgan analyst Anthony Elian has maintained an Underweight rating on Texas Capital Bancshares (NASDAQ: TCBI) and has lowered the price target from $110 to $100. https://www.openbell.ai/news/HPE:1790868643495 2026-10-01T15:30:43.495Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Close-Up-Of-Hewlett-Packard-Enterprise-L.jpg?width=250&height=187 Stock of the Day: Did Hewlett Packard Break Out? Hewlett Packard Enterprise Company (NYSE: HPE) shares are currently lower as they test a significant resistance level, which could lead to a potential breakout if surpassed. A breakout could indicate a bullish trend, allowing for higher prices as demand outstrips supply. Traders are closely monitoring the stock for any signs of movement beyond this resistance point, which may present profit opportunities. https://www.openbell.ai/news/MU:1790868359093 2026-10-01T15:25:59.093Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Image-Of-A-Micron-High-Bandwidth-Memory-.jpg?width=250&height=187 Micron's Record Quarter Points to Tighter Memory Supply Through 2028: Analysts Respond Micron Technology Inc (NASDAQ: MU) reported record fiscal fourth-quarter results, but shares fell 1.9% in early trading. Analysts have responded positively, with several raising their price targets; Rosenblatt increased theirs from $1,500 to $1,900, while D.A. Davidson raised theirs from $2,000 to $2,100. The company anticipates tighter memory markets through 2028, with over 75% of fiscal 2027 output already committed, and expects significant free cash flow, with estimates reaching up to $100 billion. https://www.openbell.ai/news/RF:1790868170595 2026-10-01T15:22:50.595Z daily 0.9 https://cdn.brandfetch.io/RF/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evercore ISI Group Maintains Underperform on Regions Financial, Lowers Price Target to $27 Evercore ISI Group analyst John Pancari has maintained an 'Underperform' rating on Regions Financial (NYSE: RF) and has lowered the price target from $31 to $27. https://www.openbell.ai/news/SPCX:1790868000037 2026-10-01T15:20:00.037Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud SpaceX Launches Crew Of Four Astronauts For NASA To International Space Station In Company's 13th Long-Duration Dragon Mission SpaceX successfully launched a crew of four astronauts for NASA to the International Space Station as part of its 13th long-duration Dragon mission. This mission marks a significant milestone in SpaceX's ongoing partnership with NASA for crewed spaceflight. The launch reinforces SpaceX's position in the aerospace industry, although specific financial figures or stock price movements were not mentioned in the article. https://www.openbell.ai/news/TGL:1790867896578 2026-10-01T15:18:16.578Z daily 0.9 https://cdn.brandfetch.io/TGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Treasure Global Reports FY26 Preliminary Revenue Of ~$56.17M, Up 22% YoY Treasure Global Inc. (NASDAQ:TGL) reported preliminary revenue of approximately $5.17 million for FY26, marking a 122% increase from $2.33 million in FY25. This growth was primarily attributed to increased sales of digital products and e-vouchers, as well as the expansion of the company's digital commerce ecosystem. The company also noted improved bottom line performance and ongoing commercial momentum. https://www.openbell.ai/news/TGL:1790867855513 2026-10-01T15:17:35.513Z daily 0.9 https://cdn.brandfetch.io/TGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Treasure Global Reports FY267 Preliminary Revenue Of ~$56.17M, Up !22% YoY Treasure Global Inc. (NASDAQ: TGL) reported preliminary financial results for the fiscal year ended June 30, 2026, with expected revenue of approximately $5.17 million, marking a 122% increase from $2.33 million in fiscal year 2025. This growth was primarily attributed to increased sales of digital products and e-vouchers, as well as the expansion of the company's digital commerce ecosystem. https://www.openbell.ai/news/SNPS:1790867793267 2026-10-01T15:16:33.267Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Konskie--Poland---November-15--2024-Syno.jpg?width=250&height=187 Synopsys, Accenture, Vicor And Other Big Stocks Moving Higher On Thursday Synopsys Inc (NASDAQ: SNPS) shares increased by 10.8% to $482.23 after the company provided fiscal-year 2027 financial guidance that exceeded estimates. The company also outlined a multi-year financial framework extending through fiscal year 2030. This uptick occurred amidst a broader market decline, with the Dow Jones index dropping over 300 points on the same day. https://www.openbell.ai/news/SGML:1790867638912 2026-10-01T15:13:58.912Z daily 0.9 https://cdn.brandfetch.io/SGML/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sigma Lithium shares are trading lower after BMO Capital downgraded the stock from Outperform to Market Perform rating and announced a $10 price target. openbell Financial News https://www.openbell.ai/news/GOOG:1790867592181 2026-10-01T15:13:12.181Z daily 0.9 https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Google wins dismissal of Chegg, Penske Media lawsuits over AI overviews'- Reuters Google has successfully won the dismissal of lawsuits filed by Chegg and Penske Media regarding the use of AI-generated overviews. The court's decision allows Google to continue its AI initiatives without the legal challenges posed by these companies. This outcome may positively impact Google's operational strategy in the AI sector. https://www.openbell.ai/news/XRPN:1790867577271 2026-10-01T15:12:57.271Z daily 0.9 https://cdn.brandfetch.io/XRPN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Armada Acquisition shares are trading higher after the company announced its shareholders approved the proposed business combination with Evernorth Holdings. openbell Financial News https://www.openbell.ai/news/MNST:1790867284028 2026-10-01T15:08:04.028Z daily 0.9 https://cdn.brandfetch.io/MNST/w/400/h/400?c=1idopYfmtR7ZKg8QMud PepsiCo, Monster Beverage Sue India Food Regulator Over Ban On 'Energy Drink' Label; PepsiCo Says India Label Ban Will Have 'Grave Commercial Consequences', Hurt 'Substantial Investments'; Monster Beverage Says India Label Ban Will Cause Financial Loss And Reputational Harm PepsiCo and Monster Beverage have filed a lawsuit against India's food regulator over a ban on labeling energy drinks, claiming it will have severe commercial consequences and negatively impact substantial investments. Monster Beverage argues that the ban will lead to financial losses and damage to its reputation. The legal action highlights the potential market implications for both companies in India. https://www.openbell.ai/news/REGN:1790867256454 2026-10-01T15:07:36.454Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Regeneron.jpg?width=250&height=187 Sanofi Deepens 20-Year Drug Development Pact With Regeneron, Pledges Up to $8 Billion Sanofi SA and Regeneron Pharmaceuticals Inc. are expanding their 20-year partnership to develop and commercialize next-generation treatments, committing up to $8 billion. This includes a $1 billion upfront payment to Regeneron and potential milestone payouts of up to $7 billion. The companies will equally share development and commercialization expenses for new therapeutic programs, while maintaining the existing profit-sharing structure for their successful drug Dupixent, which saw sales increase by 37.6% to €5.154 billion in Q2 2023. Currently, Regeneron shares are down 3.31% at $733.14, and Sanofi shares are down 0.38% at $41.08. https://www.openbell.ai/news/MRSH:1790867239484 2026-10-01T15:07:19.484Z daily 0.9 https://cdn.brandfetch.io/MRSH/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Marsh, Raises Price Target to $215 JP Morgan analyst Pablo Singzon has maintained an Overweight rating on Marsh (NYSE: MRSH) and raised the price target from $212 to $215. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/MSFT:1790867189021 2026-10-01T15:06:29.021Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Microsoft-Logo-New-York.jpg?width=250&height=187 What's Going On With Microsoft Stock? Microsoft Corp (NASDAQ: MSFT) shares are trading higher, currently at $514.63, following Wells Fargo's increase of its price target from $700 to $725. This follows a series of positive analyst ratings, including Piper Sandler raising its target to $610 and Stifel upgrading to Buy with a $575 target. The consensus Buy rating across Wall Street has an average price target of $572.33, indicating strong bullish sentiment as the stock approaches a tested ceiling between $515 and $520. https://www.openbell.ai/news/SHAZ:1790867118889 2026-10-01T15:05:18.889Z daily 0.9 https://cdn.brandfetch.io/SHAZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud SharonAI Holdings shares are trading lower. The company announced it entered into its inaugural $356 million committed senior secured, GPU-backed SPV debt facility priced at a fixed rate of 9.95%, excluding fees. openbell Financial News https://www.openbell.ai/news/USO:1790866864678 2026-10-01T15:01:04.678Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier: "Chinese refiners suspend October fuel exports to bolster stocks, sources say"- Reuters Chinese refiners have suspended fuel exports for October in an effort to bolster domestic stocks, according to sources. This decision includes PetroChina, which has canceled several cargoes. The move is expected to impact global fuel supply and may influence market dynamics, particularly for companies reliant on fuel imports. https://www.openbell.ai/news/BTCUSD:1790866820355 2026-10-01T15:00:20.355Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Bitcoin--Cryptocurrency-On-Snow--In-The-.jpg?width=250&height=187 Is Bitcoin the Best Bet for Q4? An 'Epic Run' May Be Ahead, Expert Says Bitcoin (BTC) experienced a 40% gain in Q3, with Abra CEO Bill Barhydt predicting further growth in Q4, citing factors such as scarcity and improving market structure. He noted that Bitcoin's recent performance has outpaced traditional assets, with strong ETF inflows and a significant purchase of 1,665 BTC contributing to the rally. Barhydt emphasizes Bitcoin's fixed scarcity amidst increasing fiat supply, which he believes enhances its value, while also suggesting that the current rally is characterized by lower leverage and reduced volatility compared to previous speculative movements. https://www.openbell.ai/news/NXL:1790866667716 2026-10-01T14:57:47.716Z daily 0.9 https://cdn.brandfetch.io/NXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nexalin Technology shares are trading higher after the company announced signing of a 10-year exclusive distribution agreement covering Brazil, Argentina, Chile, Uruguay, Paraguay, Ecuador and Venezuela. openbell Financial News https://www.openbell.ai/news/FHTX:1790866506399 2026-10-01T14:55:06.399Z daily 0.9 https://cdn.brandfetch.io/FHTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Foghorn Therapeutics shares are trading lower after the company and Lilly decided not to advance FHD-909 into the expansion phase and discontinued their SMARCA2 degrader collaboration. openbell Financial News https://www.openbell.ai/news/SYRE:1790866501539 2026-10-01T14:55:01.539Z daily 0.9 https://cdn.brandfetch.io/SYRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Spyre Therapeutics with Overweight Rating, Announces Price Target of $110 JP Morgan analyst Hardik Parikh has initiated coverage on Spyre Therapeutics (NASDAQ: SYRE) with an Overweight rating. The firm has set a price target of $110 for the stock. https://www.openbell.ai/news/IVAI:1790866475722 2026-10-01T14:54:35.722Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Veteran-Economist-Says-Buy-The-Dip-In-AI.jpg?width=250&height=187 Dan Ives Names 3 Under the Radar AI Stocks: ‘Starting to Get a Renaissance of Growth’ Tech analyst Dan Ives has identified three under-the-radar AI stocks: Dell Technologies (NYSE: DELL), Cisco Systems (NASDAQ: CSCO), and Hewlett Packard Enterprise (NYSE: HPE). He suggests these companies are experiencing a 'renaissance of growth' as the second, third, and fourth derivatives of AI begin to emerge. Ives also mentioned that these established firms may pursue acquisitions to enhance their positions in the AI sector, highlighting the broader potential for growth across the tech industry. https://www.openbell.ai/news/AISP:1790866366162 2026-10-01T14:52:46.162Z daily 0.9 https://cdn.brandfetch.io/AISP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Airship AI Holdings shares are trading higher after the company announced it has been awarded $29 million in firm-fixed-price contracts from an agency within the Department of Homeland Security. openbell Financial News https://www.openbell.ai/news/OBAI:1790866294023 2026-10-01T14:51:34.023Z daily 0.9 https://cdn.brandfetch.io/OBAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Our Bond shares are trading lower after the company announced a 1-for-20 reverse stock split. openbell Financial News https://www.openbell.ai/news/ACN:1790866258891 2026-10-01T14:50:58.891Z daily 0.9 https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of enterprise software companies are trading higher amid sympathy with Accenture after that company reported better-than-expected Q4 financial results and issued FY27 sales guidance above estimates. openbell Financial News https://www.openbell.ai/news/BTLN:1790866144328 2026-10-01T14:49:04.328Z daily 0.9 https://cdn.brandfetch.io/BTLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brightline Interactive shares are trading higher after the company announced the closing of a $1.25 million PIPE financing led by Dr. Allan Evans. openbell Financial News https://www.openbell.ai/news/SEV:1790866045630 2026-10-01T14:47:25.630Z daily 0.9 https://cdn.brandfetch.io/SEV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Aptera Motors shares are trading lower after the company said it still needs about $25 million to start production and $115 million to reach high-volume manufacturing, despite lowering its capital estimates. openbell Financial News https://www.openbell.ai/news/ELVN:1790865997926 2026-10-01T14:46:37.926Z daily 0.9 https://cdn.brandfetch.io/ELVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Enliven Therapeutics with Overweight Rating, Announces Price Target of $75 JP Morgan analyst Priyanka Grover has initiated coverage on Enliven Therapeutics (NASDAQ: ELVN) with an Overweight rating. The firm has set a price target of $75 for the stock. https://www.openbell.ai/news/KURA:1790865921509 2026-10-01T14:45:21.509Z daily 0.9 https://cdn.brandfetch.io/KURA/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Kura Oncology with Overweight Rating, Announces Price Target of $30 JP Morgan analyst Priyanka Grover has initiated coverage on Kura Oncology (NASDAQ: KURA) with an Overweight rating. The firm has set a price target of $30 for the company's stock. https://www.openbell.ai/news/LIFE:1790865692498 2026-10-01T14:41:32.498Z daily 0.9 https://cdn.brandfetch.io/LIFE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Ethos Technologies; Hunterbrook Media Issues Report Titled, “How Ethos Sold Wall Street on AI While Powering an Analog Boiler Room”; States Hunterbrook Capital Is Short $LIFE Hunterbrook Media has released a report titled 'How Ethos Sold Wall Street on AI While Powering an Analog Boiler Room,' which raises concerns about Ethos Technologies. The report indicates that Hunterbrook Capital is taking a short position on the stock of Ethos, trading under the ticker $LIFE. Specific financial figures or market impacts were not disclosed in the article. https://www.openbell.ai/news/NCI:1790865550200 2026-10-01T14:39:10.200Z daily 0.9 https://cdn.brandfetch.io/NCI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Neo-Concept International shares are trading lower after the company announced a registered direct offering of 250,000 shares and 1.75 million pre-funded warrants priced at $1.00 per share equivalent. openbell Financial News